IALYLQQNW

Catalog No.: A50753
Immunogenic Peptide
IALYLQQNW is an immunogenic nonapeptide derived from the latent membrane protein 1 (LMP1) of the Epstein-Barr virus (EBV). As a latent T-cell epitope, IALYLQQNW effectively activates EBV-specific cytotoxic T lymphocytes (CTLs), facilitating the recognition and destruction of EBV-infected cells. This peptide is significant for investigating immune responses to EBV-associated malignancies, including Hodgkin's disease and nasopharyngeal carcinoma. It serves as a valuable tool for research into targeted immunotherapies and vaccine development against these cancers.
Grouped product items
Size Price Stock Qty
1mg
$40.00
In stock
5mg
$80.00
In stock
10mg
$135.00
In stock
Bulk Size
Bulk Discount
Free Delivery on orders over $500
Research use only. We do not sell to patients.

Loading distributor info...

Adooq Products cited in reputable paper
Science VOLUME 380, ISSUE 6663 (2023)
Science VOLUME 369, ISSUE 6510 (2020)
Science VOLUME 356, ISSUE 6336 (2017)
Cell Vol. 185 Issue 23 p4428-4447.e28
Cell Vol 177, Issue 7, p1933-1947.e25
Cell Vol 156, Issue 5, p857-1114
Nature Volume 622 Issue 7982 (2023)
Nature volume 620, pages890-897 (2023)
Nature volume 610, pages540-546 (2022)
Nature volume 588, pages83-88 (2020)
Nature volume 574, pages268-272 (2019)
Nature volume 573, pages539-545 (2019)
Nature volume 567, pages118-122 (2019)
Nature volume 551, pages639-643 (2017)
Nature volume 551, pages247-250 (2017)
Nature volume 548, pages356-360 (2017)
Nature volume 545, pages187-192 (2017)
Biological Activity
DescriptionIALYLQQNW is an immunogenic nonapeptide derived from the latent membrane protein 1 (LMP1) of the Epstein-Barr virus (EBV). As a latent T-cell epitope, IALYLQQNW effectively activates EBV-specific cytotoxic T lymphocytes (CTLs), facilitating the recognition and destruction of EBV-infected cells. This peptide is significant for investigating immune responses to EBV-associated malignancies, including Hodgkin's disease and nasopharyngeal carcinoma. It serves as a valuable tool for research into targeted immunotherapies and vaccine development against these cancers.
Product Information
Catalog NumA50753
FormulaC55H81N13O14
Molecular Weight1148.31
CAS Number610268-80-9
SequenceIle-Ala-Leu-Tyr-Leu-Gln-Gln-Asn-Trp
Sequence shorteningIALYLQQNW
SMILESOC(C=C1)=CC=C1C[C@H](NC([C@H](CC(C)C)NC([C@H](C)NC([C@@H](N)[C@@H](C)CC)=O)=O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@H](C(O)=O)CC2=CNC3=CC=CC=C23)=O)=O)=O)=O)=O
Useful Calculator

This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass

    Concentration

    Volume

    Molecular Weight

Please check COA/MSDS for correct molecular weight.

Calculate the dilution required to prepare a stock solution.
This equation is commonly abbreviated as: C1V1 = C2V2

  • C1

    V1

    C2

    V2